Clinical remission in rheumatoid arthritis: Data from the early arthritis cohort study CAPEA;Klinische Remission bei rheumatoider Arthritis: Daten aus der Früharthritiskohortenstudie CAPEA

Zeitschrift fur Rheumatologie

Volumn 75, Issue 1, 2016, Pages 90-96

  Albrecht, K ^a   Callhoff, J ^a   Edelmann, E ^b   Schett, G ^c   Schneider, M ^d   Zink, A ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b Neurological Clinic Bad Aibling   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antirheumatic agents; Combination drug therapy; Glucocorticoids; Prognosis; Treatment outcome

Indexed keywords

BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; PREDNISOLONE; ANTIRHEUMATIC AGENT;

ARTICLE; DATA BASE; DISEASE ACTIVITY SCORE; FOLLOW UP; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; TREATMENT PLANNING; TREATMENT RESPONSE; ARTHRITIS, RHEUMATOID; COHORT ANALYSIS; COMBINATION DRUG THERAPY; FEMALE; GERMANY; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PROCEDURES; RISK FACTOR; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GERMANY; GLUCOCORTICOIDS; HUMANS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; PREVALENCE; REMISSION INDUCTION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84959136587     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-015-0019-5     Document Type: Article

References (9)

1. Albrecht K, Callhoff J, Schneider M et al (2015) High variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort. Rheumatol Int 35(8):1377–1384
2. Edelmann E (2014) Schnittstellen in der ambulanten und stationären rheumatologischen Versorgung. Z Rheumatol 73:505–513
3. Krüger K, Wollenhaupt J, Albrecht K et al (2012) S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2011: adaptierte EULAR Empfehlungen und aktualisierter Therapiealgorithmus. Z Rheumatol 71:592–603
4. Krüger K (2014) O’Dell reloaded: Setzen wir TNF-Inhibitoren zu schnell ein? Z Rheumatol 73:111–112
5. Schneider M, Lelgemann M, Abholz HH et al (2011) Interdisziplinäre Leitlinie. Management der frühen rheumatoiden Arthritis, 3. Aufl. Springer, Heidelberg
6. Schneider M, Krüger K (2013) Rheumatoide Arthritis – Frühdiagnose und Krankheitskontrolle. Dtsch Arztebl 110:477–484
7. Smolen JS, Breedveld FC, Burmester GR et al (2015) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. doi:10.1136/annrheumdis-2015-207524. (Epub ahead of print)
8. Smolen JS, Landewe R, Breedveld FC et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492–509
9. Wallin H, Seddighzadeh M et al (2011) Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT tria. Ann Rheum Dis 70(3):469–475